Tissue transglutaminase IgA (tTG-IgA) is an autoantibody directed against the enzyme transglutaminase 2, which is the primary autoantigen in celiac disease. It is the first-line serological test recommended for celiac disease screening due to its high sensitivity (>90%) and specificity (>95%) in IgA-sufficient individuals. Elevated levels strongly correlate with intestinal villous atrophy and serve as both a diagnostic and monitoring marker. Transglutaminase 2 (TG2) is a ubiquitous enzyme involved in cross-linking proteins, including deamidation of gliadin peptides derived from dietary gluten, which enhances their immunogenicity in genetically susceptible individuals (HLA-DQ2/DQ8). In celiac disease, immune activation against TG2 leads to IgA autoantibody production, intestinal inflammation, and progressive villous atrophy of the small bowel mucosa. The degree of tTG-IgA elevation generally reflects the intensity of ongoing gluten-driven immune activation.
This blood test checks for an antibody your immune system makes when it reacts to gluten, and a positive result is a strong signal that celiac disease may be present. If you have already been diagnosed with celiac disease, this test helps your doctor see whether your gluten-free diet is working.
When elevated: Elevated tTG-IgA, particularly at levels ≥10× the upper limit of normal, is strongly associated with celiac disease and significant small intestinal villous atrophy (Marsh 3 lesions). Persistently elevated levels in a diagnosed patient on a gluten-free diet suggest ongoing gluten exposure, dietary non-adherence, or refractory celiac disease, and warrant further clinical evaluation. Untreated or poorly controlled celiac disease is associated with increased risk of malabsorption, nutritional deficiencies, osteoporosis, and small bowel lymphoma. When low: A low or undetectable tTG-IgA in an IgA-sufficient individual on a gluten-containing diet makes active celiac disease unlikely, though it does not entirely exclude seronegative celiac disease, which occurs in a small minority of biopsy-confirmed cases. In a patient with known celiac disease on a gluten-free diet, normalization of tTG-IgA is a favorable indicator of mucosal recovery and dietary adherence. Very low or absent levels have no independent adverse clinical significance beyond their diagnostic context.
tTG-IgA is not athlete-specific but relevant to active individuals if celiac disease is suspected. Undiagnosed celiac disease can impair nutrient absorption (iron, B12, folate), reduce energy availability, delay recovery, and increase injury risk; screening may help explain persistent fatigue, GI distress during training, or performance plateaus.
Turnaround Time
4 days (up to 6 days)
Fasting Required
No
Order online
Choose your lab and check out. We send your lab requisition automatically — no doctor visit needed.
Get your sample collected
Visit a lab service center near you for a quick blood draw (or book at-home phlebotomy where available).
See your results
Your results land in your Insider portal, ready to review and act on — that easy.
Your price
$40.00$120
3.0× less than retail
Versus the typical direct-to-consumer retail price for this test (illustrative — consumer prices vary by provider and region).
$40.00
$40.00
$45.00
Peer-reviewed sources supporting the educational content on this page.